A lipid profile or lipid panel is a Test panel of used to find abnormalities in blood lipid ( such as cholesterol and ) concentrations. The results of this test can identify certain genetic diseases and can determine approximate risks for cardiovascular disease, certain forms of pancreatitis, and other diseases.
Lipid panels are usually ordered as part of a physical exam, along with other panels such as the complete blood count (CBC) and basic metabolic panel (BMP).
LDL is not usually actually measured, but calculated from the other three using the Friedewald equation. A laboratory can optionally calculate the two extra values from the report:
For healthy adults with no cardiovascular risk factors, the ATP III guidelines recommend screening once every five years. A lipid profile may also be ordered at regular intervals to evaluate the success of lipid-lowering drugs such as .
In the pediatric and adolescent population, lipid testing is not routinely performed. However, the American Academy of Pediatrics and the National Heart, Lung, and Blood Institute (NHLBI) recommend that children aged 9–11 be screened once for severe cholesterol abnormalities. This screening can be valuable to detect genetic diseases such as familial hypercholesterolemia that can be lethal if not treated early.
Traditionally, most laboratories have required patients to fast for 9–12 hours before screening. However, studies have questioned the utility of fasting before lipid panels, and some diagnostic labs routinely accept non-fasting samples.
From these three data LDL may be calculated. According to Friedewald's equation:
cited in
VLDL can be defined as the total cholesterol that is neither HDL nor LDL. With that definition, Friedewald's equation yields:
The Friedewald method is reasonably reliable for the majority of patients, but is notably inaccurate in patients with hypertriglyceridemia (> 400 mg/dL or 4.5 mmol/L). It also underestimates LDL-C in patients with low LDL-C (< 25 mg/dL or 0.6 mmol/L). It does not take into account intermediate-density lipoprotein.
A "Martin/Hopkins" variation that takes into how triglycerides-to-VLDL ratio tends to vary with other parameters appears more reliable and accurate.
Laboratories may also use proprietrary tests for "direct chemical LDL-C" which require no prior separation by centrifugation. These tests are not yet standardized in US and Europe and lack validation. A specific version of the test seems popular in Japan, however. A number of other LDL-C determination methods have been used in the past or have been proposed for future use.
A total cholesterol reading can be used to assess an individual's risk for heart disease; however, it should not be relied upon as the only indicator. The individual components that make up total cholesterol reading—LDL, HDL, and VLDL—are also important in measuring risk.
For instance, someone's total cholesterol may be high, but this may be due to very high HDL ("good cholesterol") cholesterol levels,—which can help prevent heart disease (the test is mainly concerned with high LDL, or "bad cholesterol" levels). So, while a high total cholesterol level may help give an indication that there is a problem with cholesterol levels, the components that make up total cholesterol should also be measured.
The alternative calculations mentioned above may yield significantly different values for VLDL.
All-direct
Implications
Lipid Profiling in Diabetes Risk Prediction
Further reading
|
|